Rua Bioscience Limited (NZE:RUA)
New Zealand · Delayed Price · Currency is NZD 0.0460
-0.0020 (-4.17%)
Aug 14, 2025, 3:36 PM NZST
ANSYS Market Cap
Rua Bioscience has a market cap or net worth of 10.82 million as of August 13, 2025. Its market cap has increased by 27.75% in one year.
Market Cap
10.82M
Enterprise Value
10.79M
Revenue
1.06M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.05
Market Cap Chart
Since October 22, 2020, Rua Bioscience's market cap has decreased from 95.21M to 10.82M, a decrease of -88.64%. That is a compound annual growth rate of -36.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 10.82M | 76.91% |
| Dec 31, 2024 | 6.11M | -67.78% |
| Dec 29, 2023 | 18.98M | -44.14% |
| Dec 30, 2022 | 33.97M | -45.52% |
| Dec 31, 2021 | 62.37M | -25.89% |
| Dec 31, 2020 | 84.16M | -11.61% |
| Oct 22, 2020 | 95.21M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Fisher & Paykel Healthcare Corporation | 21.73B |
| EBOS Group | 8.22B |
| Summerset Group Holdings | 2.60B |
| Ryman Healthcare | 2.37B |
| Oceania Healthcare | 470.75M |
| AFT Pharmaceuticals | 274.75M |
| Green Cross Health | 125.03M |
| Radius Residential Care | 112.19M |